TETI, ANNA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 6.942
EU - Europa 4.048
AS - Asia 2.192
SA - Sud America 35
OC - Oceania 9
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.232
Nazione #
US - Stati Uniti d'America 6.927
IE - Irlanda 1.172
CN - Cina 1.045
SE - Svezia 775
TR - Turchia 664
DE - Germania 514
SG - Singapore 411
IT - Italia 390
UA - Ucraina 384
GB - Regno Unito 376
FI - Finlandia 194
FR - Francia 135
BR - Brasile 33
BE - Belgio 26
IN - India 26
RU - Federazione Russa 22
VN - Vietnam 18
NL - Olanda 15
CZ - Repubblica Ceca 12
AT - Austria 8
CA - Canada 8
AU - Australia 6
IL - Israele 6
JP - Giappone 6
MX - Messico 4
EG - Egitto 3
ES - Italia 3
LT - Lituania 3
NZ - Nuova Zelanda 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
EU - Europa 2
GR - Grecia 2
HK - Hong Kong 2
KR - Corea 2
MK - Macedonia 2
PT - Portogallo 2
RO - Romania 2
TW - Taiwan 2
AL - Albania 1
AR - Argentina 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
PR - Porto Rico 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 13.232
Città #
Jacksonville 1.497
Chandler 1.288
Dublin 1.169
Boardman 533
Santa Clara 434
Izmir 320
Singapore 317
San Mateo 301
Nanjing 280
Wilmington 277
Lawrence 201
Princeton 201
New York 196
Ann Arbor 140
Woodbridge 110
Ashburn 104
Milan 95
Nanchang 92
Shenyang 87
Seattle 85
L'aquila 69
Mountain View 67
Des Moines 66
Verona 60
Tianjin 58
Falls Church 57
Beijing 56
Hebei 47
Bremen 43
Jiaxing 43
Kunming 43
Shanghai 38
Dearborn 34
Kitzingen 33
Ningbo 31
Changsha 28
Philadelphia 27
Jinan 26
L’Aquila 26
Guangzhou 25
Norwalk 25
Los Angeles 24
Zhengzhou 21
Brussels 20
Rome 20
Dallas 18
Dong Ket 18
Helsinki 17
Pune 16
Fremont 14
Tappahannock 13
Brno 12
Houston 12
Lanzhou 12
Taizhou 12
Nuremberg 11
Hangzhou 9
Munich 9
Pescara 9
Aquila 8
Auburn Hills 8
Fuzhou 8
Strasbourg 8
Changchun 7
Düsseldorf 7
Fairfield 6
Hefei 6
Redwood City 6
Washington 6
West Jordan 6
Lappeenranta 5
London 5
Moscow 5
Paris 5
Redmond 5
Würzburg 5
Chongqing 4
Ghent 4
Shangdi 4
Xian 4
Adelaide 3
Amsterdam 3
Chicago 3
Edinburgh 3
Frankfurt am Main 3
Harbin 3
Istanbul 3
Jinhua 3
Manoppello 3
Mexico City 3
Plymouth 3
Shijiazhuang 3
Stockholm 3
São Paulo 3
Teramo 3
Tokyo 3
Toronto 3
Toulouse 3
Athens 2
Auckland 2
Totale 9.076
Nome #
SMALL INTERFERING RNA (siRNA) PER LA TERAPIA DELL’OSTEOPETROSI AUTOSOMICA DOMINANTE DI TIPO 2 (ADO2) CAUSATA DA MUTAZIONE DEL GENE CLCN7 (ADO2 CLCN7-DIPENDENTE) 145
Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis 112
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 110
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 106
CALCITONIN DOWN-REGULATES IMMEDIATE CELL SIGNALS INDUCED IN HUMAN OSTEOCLAST-LIKE CELLS BY THE BONE SIALOPROTEIN-IIA FRAGMENT THROUGH A POSTINTEGRIN RECEPTOR MECHANISM 99
Oligodeoxynucleotide targeted to the alpha(v) gene inhibits alpha(v) integrin synthesis, impairs osteoclast function, and activates intracellular signals to apoptosis 97
The role of the AlphaVbeta3 integrin in the development of osteolytic bone metastases: A pharmacological target for alternative therapy? 94
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk 91
Osteoplastic activity of mature osteocytes evaluated by H-proline incorporation. 89
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 89
The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro 87
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 87
Ultrastructural study of human adrenal pheochromocytoma by open needle biopsy. 84
Modulation of estrogen receptor levels in mouse uterus by protein kinase C isoenzymes 84
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models 83
Osteoclast isolation: New developments and methods 83
PLEKHM1 is involved in osteoclastic vesicular transport and mutations in this gene cause osteopetrosis in incisors absent rat and human 83
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 83
Bone metastasis: pathogenesis and therapeutic implications 82
P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy 82
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 82
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 82
Signaling in osteoblasts integrates bone remodeling and energy metabolism 81
Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood 81
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling 81
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 81
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 81
The "love-hate" relationship between osteoclasts and bone matrix 81
The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss 80
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study 80
An antisense oligonucleotide targeting the alpha V integrin gene inhibits adhesion and induces apoptosis in breast cancer cells 80
Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV) 80
Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology 80
Tyrosine kinase Src inhibitors: Potential therapeutic applications 80
Congenital disorders of bone and blood 80
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 80
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 79
OSTEOCLAST CYTOSOLIC CALCIUM, REGULATED BY VOLTAGE-GATED CALCIUM CHANNELS AND EXTRACELLULAR CALCIUM, CONTROLS PODOSOME ASSEMBLY AND BONE-RESORPTION 79
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 79
Melanoma cells stimulate osteoclastogenesis, c-src expression and osteoblast cytokines 78
Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders 77
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature" 77
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 76
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 76
Protein kinase C modulates estrogen receptors in differentiated osteoblastic cells in vitro 76
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and Matrigel invasion 76
Bone cells and the mechanisms of bone remodelling 76
ROUS-SARCOMA VIRUS-TRANSFORMED FIBROBLASTS AND CELLS OF MONOCYTIC ORIGIN DISPLAY A PECULIAR DOT-LIKE ORGANIZATION OF CYTOSKELETAL PROTEINS INVOLVED IN MICROFILAMENT MEMBRANE INTERACTIONS 76
Effects of advanced glycation end products on cytosolic Ca2+ signaling of cultured human mesangial cells 76
Non-conventional role of haemoglobin beta in breast malignancy 76
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo [2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway 75
Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro 75
Association of intermediate osteopetrosis with poikiloderma 75
A six-gene signature predicting breast cancer lung metastasis 75
Osteoclast-poor human osteopetrosis due to mutations in RANKL 75
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 74
Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent 74
Influence of calcium depletion on medullary bone of laying hens. 74
THE EFFECTS OF PARATHYROID-HORMONE OR 1,25-DIHYDROXYVITAMIN-D3 ON MONOCYTE-OSTEOCLAST FUSION 74
A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in chinese hamster ovary (CHO) cells 74
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone 74
Apoptosis-associated speck-like protein containing a caspase-1 recruitment domain (ASC) contributes to osteoblast differentiation and osteogenesis 74
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 73
The Great Beauty of the osteoclast 73
Apparent cure of a newborn with malignant osteopetrosis using prednisone therapy 73
CALCITONIN INCREASES CYTOSOLIC-FREE CALCIUM-CONCENTRATION VIA CAPACITATIVE CALCIUM INFLUX 73
Interaction of estrogen receptor a with protein kinase C alpha and c-Src in osteoblasts during differentiation 72
EFFECTS OF CALCIUM-PHOSPHATE-BASED MATERIALS ON PROLIFERATION AND ALKALINE-PHOSPHATASE ACTIVITY OF NEWBORN RAT PERIOSTEAL CELLS-INVITRO 72
NEW MODEL FOR BONE-RESORPTION STUDY IN-VITRO - HUMAN OSTEOCLAST-LIKE CELLS FROM GIANT-CELL TUMORS OF BONE 72
the effect of microgravity on osteoblast metabolism 72
Cell-substratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures. 71
CALCIUM RELEASE-ACTIVATED CALCIUM INFLUX IN CULTURED HUMAN MESANGIAL CELLS 71
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 71
OSTEOBLAST-OSTEOCLAST RELATIONSHIPS IN BONE-RESORPTION - OSTEOBLASTS ENHANCE OSTEOCLAST ACTIVITY IN A SERUM-FREE COCULTURE SYSTEM 70
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice 70
Mature osteocytes behaviour in a repletion period: the occurrence of osteoplastic activity. 70
Imbalance of osteoclastogenesis-regulating factors in celiac disease 70
Kinome profiling of osteoblasts on hydroxyapatite opens new avenues on biomaterial cell signaling 70
REGULATION OF CELLULAR FUNCTIONS BY EXTRACELLULAR-MATRIX 70
Type II benign osteopetrosis (Albers-Schonberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations 69
Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio 69
Tartronates: A new generation of drugs affecting bone metabolism 69
Impaired skeletal development in interleukin-6 transgenic mice. A model for the impact of chronic inflammation on the growing skeletal system 69
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 69
Decreased c-Src expression enhances osteoblast differentiation and bone formation 69
Microgravity induces apoptosis and increases interleukin 6 expression in osteoblast-like cells. 69
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 68
beta 1 Integrin antisense oligodeoxynucleotides: utility in controlling osteoclast function 68
A novel calcium sensor stimulating inositol phosphate formation and [Ca2+](i) signaling expressed by GCT23 osteoclast-like cells 68
Immediate cell signal induced by laminin in rat Sertoli cells 68
EFFECT OF VITAMIN-A ON BONE-RESORPTION - EVIDENCE FOR DIRECT STIMULATION OF ISOLATED CHICKEN OSTEOCLASTS BY RETINOL AND RETINOIC ACID 68
Increase in cytosolic Ca2+ induced by elevation of extracellular Ca2+ in skeletal myogenic cells 67
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 67
Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: A new biological and clinical parameter for prostatic carcinoma 66
Colony stimulating factor-1-induced osteoclast spreading depends on substrate and requires the vitronectin receptor and the c-src proto-oncogene 66
Osteoclast receptors and signaling 66
Recent advances in mesenchymal stem cell immunomodulation. The role of microvesicles 65
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 65
Monocytes from circulating blood fuse in vitro with purified osteoclasts in primary culture. 65
ADHESION PROPERTIES AND INTEGRIN EXPRESSION OF CULTURED HUMAN OSTEOCLAST-LIKE CELLS 65
Totale 7.758
Categoria #
all - tutte 59.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.312


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.026 0 0 0 0 0 273 318 10 195 27 4 199
2020/20211.726 44 222 1 195 194 89 199 15 206 93 363 105
2021/20221.438 89 136 343 91 62 39 33 83 103 26 77 356
2022/20233.649 285 188 69 368 349 419 5 279 1.499 14 116 58
2023/2024922 125 53 66 163 60 264 17 21 5 30 12 106
2024/20251.359 53 51 319 135 457 344 0 0 0 0 0 0
Totale 13.372